Alamar Biosciences, Inc.

Just one day left to register for tomorrow's Precision Biomarker Summit in Boston! Join Alamar and key opinion leaders from Johnson & Johnson Innovative Medicine, Harvard Medical School & Boston Children's Hospital, Brigham and Women's Hospital, and Biognosys, for a discussion on the latest advances in protein biomarker research with an introduction to #NULISA: A precision proteomics platform with ultra-high sensitivity and high multiplex from blood. Register now to save your seat👉 https://ow.ly/Ljrm50TVPcW

Join us at #ASHG2024 in Denver, CO, next week to see how you can elevate your genomics research with the groundbreaking #NULISA Proteomics Platform! Explore how to integrate high-sensitivity and multiplexed protein detection into your research with Dr. Carlos Cruchaga from Washington University School of Medicine in St. Louis during our Industry Lunch Symposium on Nov. 6, 12-1pm in room 107. Don’t miss out on the opportunity to network and learn by visiting booth 1065. Learn more 👉 https://ow.ly/l4cI50TUTlq

✈️ We're headed to Boston for our next Precision Biomarker Summit on October 30. Featuring presentations from Dr. Chris Whelan, with Johnson & Johnson Innovative Medicine, Dr. Hanno Steen, with Harvard Medical School & Boston Children's Hospital, Dr. Jessica Lasky-Su, with Brigham and Women's Hospital & Harvard Medical School, and Dr. Nigel Beaton, with Biognosys, join us for a discussion on the latest advances in protein biomarker research with an introduction to #NULISA: A precision proteomics platform with ultra-high sensitivity and high multiplex from blood. Don’t miss this opportunity to connect, collaborate, and explore the future of #proteomics. Register today 👉 https://ow.ly/Uwos50TIvZB

We are excited to announce our participation at the 2nd Fluid & Imaging Biomarkers & Endpoints in Neuroscience Forum in Boston this week. Join us as we lead panel discussions with experts in the field, to explore the future of neuroscience and advance precision medicine in the CNS! 🧠🔬 Stay up to date on all upcoming conferences and events 👉 https://ow.ly/vkAg50TRkAF #Neuroscience #Multiomics #PrecisionMedicine #Biomarkers

Thank you to all who joined our lunch symposium at #HUPO2024 with featured presentations by Dr. Hanno Steen from Harvard University and Boston Children's Hospital along with Dr. Kristina Beeler from Biognosys If you’re interested in learning about #NULISA or would like a demo of the #ARGO HT System, please come by Booth 25. We’d love to show you more. #proteomics #immunoassay #massspec #drugdiscovery

🧠 Alamar Biosciences' NULISAseq CNS Disease Panel 120 is gaining significant interest from Alzheimer's researchers. Measuring 120+ proteins linked to neurological diseases, the new panel offers a more comprehensive view of Alzheimer's beyond traditional amyloid biomarkers. Researchers like Dr. Thomas Karikari from the University of Pittsburgh have used the panel in recent studies, identifying key proteins linked to Alzheimer's progression, and are hopeful about its potential in diagnostics. Read the full GenomeWeb article for more 👉 https://ow.ly/opHS50TPbOE #AlzheimersResearch #Biomarkers #Neuroscience #Proteomics

Welcome to #HUPO2024! Come talk with Mathias Holpert, Xiao-Jun Ma, Yuling Luo, Anna Berdine, Max Mahoney, or Michael Evans at booth 25 to learn more about #NULISA and how to apply ultra-sensitive protein detection from biofluids to your research! Also, don’t miss our lunch symposium, Tuesday, October 22 at 12pm in the plenary hall with Drs Hanno Steen from Harvard University and Kristina Beeler from Biognosys.

#HUPO2024 is days away! Don't miss our Industry Lunch Symposium on October 22, featuring presentations from Dr. Hanno Steen of Harvard Medical School and Boston Children's Hospital and Dr. Kristina Beeler of Biognosys. Tune in to hear how experts around the globe are using #NULISA technology to advance the field of proteomics. Swing by booth 25 to speak with our team about your research goals and to demo the fully-automated #ARGO HT System 👉 https://lnkd.in/gNgr2SmY #Proteomics #NULISA #Biomarkers

Attending #HUPO2024 in Dresden next week? Swing by the poster sessions on Oct. 23 to hear from Xiao-Jun Ma, CTO at Alamar, share our latest findings on the ultrasensitive profiling of over 300 plasma proteins to predict biological age. This study harnesses the power of #NULISA technology to explore age-related changes in protein levels, providing a new, non-invasive approach to understanding biological aging. Stop by booth 25 for a live demo of the fully auotmated #ARGO HT System, or click the link to schedule a 1:1 meeting with one of our experts to discuss your research goals 👉 https://ow.ly/lG4l50TNTut

💡Ideas start with builders and innovators💡 We are thrilled to announce that Yuling Luo, CEO at Alamar, has been honored by Goldman Sachs as one of the Most Exceptional Entrepreneurs at the 2024 Builders and Innovators Summit. We are honored to be recognized alongside this year's cohort, and look forward to engaging in creative conversations with the best and brightest. #GSInnovators